QQ客服 官方微博 反馈留言

	MiR-142 inhibits the development of cervical cancer by targeting HMGB1.
	Jiang, Daqiong; Wang, Huiyan; Li, Zhuyan; Li, Zhen; Chen, Xin; Cai, Hongbing*
刊名	Oncotarget
	2017
卷号	8期号:3页码:4001-4007
关键词	miR-142 HMGB1 cervical cancer
DOI	10.18632/oncotarget.13136
URL标识	查看原文
WOS记录号	WOS:000393228400022;PMID:27829233
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3375148
专题	武汉理工大学
作者单位	1.[Li, Zhen 2.Chen, Xin 3.Cai, Hongbing 4.Li, Zhuyan 5.Jiang, Daqiong] Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Tumor Biol Behav, Dept Gynecol Oncol,Hubei Canc Clin Study Ctr, Wuhan 430071, Hubei, Peoples R China.
推荐引用方式 GB/T 7714	Jiang, Daqiong,Wang, Huiyan,Li, Zhuyan,et al. MiR-142 inhibits the development of cervical cancer by targeting HMGB1.[J]. Oncotarget,2017,8(3):4001-4007.
APA	Jiang, Daqiong,Wang, Huiyan,Li, Zhuyan,Li, Zhen,Chen, Xin,&Cai, Hongbing*.(2017).MiR-142 inhibits the development of cervical cancer by targeting HMGB1..Oncotarget,8(3),4001-4007.
MLA	Jiang, Daqiong,et al."MiR-142 inhibits the development of cervical cancer by targeting HMGB1.".Oncotarget 8.3(2017):4001-4007.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。